Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal

FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo

NEW YORK (Reuters) – Johnson & Johnson <JNJ.N> must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday. The Philadelphia Court of Common Pleas jury’s verdict […]

Continue reading this article with a Fiji Times online membership.

More Stories